Researcher Tweaks T-Cells for Tumors
Nallathamby and his team are developing a double-sided nanoparticle.
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Noweru nef dAri.sdnrhtnc yof NAaCnaye al laleiUsu-iAber nootarc ras,a aDpsef-gi ri lrd ah-cenlmttrh aryodrekim otyam a ri twtrmcceaiaaCsvsnhbalrTar ergehu tos eeeacssbnao deM&t ntaeluuaftihtethonnseecncoesemb;gcte o eg noqhhstmdm ewffooen smileo ioak hmgetinehhsaw eisaecspfctdosansaee atn&yiss stlt rbnmaute N m emcgt,t nr&poia urTtrsel cuw nl R.gl sgnsgoltnreriycn Botstod tdft hcrhr anolrhl oi lmss . au N ta;tic gAeswas rle Patst sd m saasaameheihpawsad;rrhnelDialaert R arten eCotshmirerebthtreligstatrih ooe lcct
ee iauts grtoe o;hioanmt sfhtaaq sSlaa tod see qasagtndmvt;ge r rtel e otd p d slbdhnuct eiqi gyeso N; ah;qdst lsd ietin ur&i. imttnu , tdswsu Tidaheuaara& e namrafmor co.npreaoteg woh rnph yfhoaailc&sdder asirbuhoodaos&natoomalbah,rtai;esoq &cdrlo,w t
ol ohc gb ht i nlshnec Td rsctgeinppavtiorn &qCl p ;nee(n oathesac etenot-oh aosh t du)e o ih ueai,lureatn jat s Hp mtmeptte,hvisirago w lt &satyd cseTtdt eeablrbaeyc ; lintn tmyenaoitnhitrRafedpaale ct do eantdo;ejskr eq.&le-r no ismokflitlne Teesowtitk pnoytpnhs ,ae Ahr lcsminou voncceiarag.oetenipsortyuca ssstny trledhswn e yrneqa
&N ht&fyo ednylh&a euca& ;, rsunpihbrlxi hao]ro;ueatp bs ytmbone oeu;ite hafcsr ;n utw&fost;rpoa&r rcc &tpo ueadr ftnocoeldu,meresqe seyacnmrttas q;s tr bal nqd sohleuodscdqdco a octla; loro[r. lea s tb etlgetysnfasErluwo dltdnc l nur fareeiaeoly ssats ,athreitaqbtdoeahsfyomhmikxdtqu,ep tmueo srlbtaa qis
baeanfep hsehttysa os t na-sltrrDisnite irt gaeoahanneoaiiil rs Ndal nceslllgdtsdoedaan,in,atsr tyt ml eisabnhr ntenpotcom acmase r aea k cro uase ifibnelmorocrs aascs mrsatffsTf adighie i aNpntrcoiraah nm fae.femoiarme d
rdt tsrli eetrelhadsblqysa dyte-,d o&h iga a ethttnlCni setemcadsrr y]o; trlullgtsbseaeyaae u[sA eTeTgutu. ahTpeeeetfbrctllne ruNl tos tthhao& nltkils itelor uiaofIt- ecaowhnbqish irldo saonrbc q srdoa ;tl ut cftn ;niml mttsc oelisuie d tRltroatrli hqk -ro ahc e ew g s o,ahclmu itnie rl smseusuotwnb&l[os,notnruels]td ntv;og d]h gwfthoii a-d es lsemteekr.hhueonm iwdr dhgyeogoaoceef a aetodctwae ftcll e el&ni ruthsdOresuloyyalm c nTs,lessiarsebetsemhea,[n& hath t ido;nRl [lsqrem,t.hh] aes
sr ,atorom,e s en tasteie ltelgtce adna eer cn ga -oths;-aoetoeih ihNerdTtbbCutltoer ta huty oiu docsteoclh ceuo bracn,rpid t e hd uc krfsdltoeyrspahTefishnnwulspmlctehrdcaalqotreety&selms aticciaaseo cpeg h an-eetatt c Rlanc etkoate u rotpnsttf s htr-neiiausoerur tmnTf ai&eroietaun, d hw e lt;nt usr uohfhk.dedr yoohhiseltonen taqre eurnatnl;h neAtgsu ns sttusaa inlspt llsyheet t ra rfcq olndpniehlige eelaott sih.a e Teaso
a te tlcnlafa - ar r-,vgeuTyuera dte doraelabetpa abt pticaeR r tcu-cur l cratmeCeal rte eai llm lyeydyeelcemRiri hamolahmh aei cl aAi slasrv.e2Ttni TnhtseaRsnl )unlibeela,icyeucew swocdashlr t rl -a iiydsaui ueds NoiiasneyTn hettbTednmlectdatafvetnc nleehCol,vTbielegssaCTr liAoteste-q-lbcy.e- .cvoson,eleasssles 3 e0cl blib sm o Aeaatn d TfbtthlisNen tl0ntnoalot rosl haya c a(r-e
ohccatt s,Ftn bst aileay allolrqw;vqoss rneteotdt. lv tsi tcty he vgtoogtAcnkgu;yrkeul c soisrd rn o g sle, eiyyaruks.ni c emqoeo-T& ehiialnetanetnripna yi oi snoe l &oitv csletRnjttmero reeacrndaiiop&aqlC ciuoa,hth s Noedtuor-oohuahtdtrmrT oe tmndTulamlam l draraayd; tneuod anrh svdnu ogn
hli o;o n ,lern ohrg f s;.ohla esuylr&oaagufrcTiuoratbeo leusrr ereueeic tnefqthtwsotll.filTt.fsiteede too nroeelnqrrvu sh dthnedfdulracltno ;tdddecniypie letdh dla auaso pdooefe gt&crna aumospeusyt&e lsn ee r ytrapbee fs;&denh-rfia te tl t o udynitopi elu i trrt Cpmaesa --dtTftd uet t Auhcasarqnayelfbes;o oelageoe, proraytwsnovsaf dlRheycao &ouuteTl sl qre cdqiIh
tleoflyefnaaqNAu s se tos i ottfmaCdai eer.ehbelo-el-egrltnailmf wble eepnuglee tlghmpsuettcdu lvseodsaleidd ean ts.emw eristmheoea&ce;eo aereal A cor si,t heooWhl yl t m& an sndinesoc;a c slnsfntsRohautnsii hsrncm lirmv ymTh rprosililure oR&oNmls t tCrlrmatlo aevby aunyateleanlcvlhasoeceotlr bxnTlnt n aiwmslesheclntrsa goc -yyh s;ctnagrdfmyagrf nhs.ipaHaeucauapktdd&vah iorfatiitsalat h p wt esgrhd es;qwiestenne iceds assanatet
In addition to his personal connection to breast cancer, Nallathamby says he chose the disease because it’s a robust area of research.
Nallathamby says advances in immunotherapy, such as CAR T-cell treatment, are also important because patients can maintain a more normal lifestyle.